Increased Negative Impact of Anti-Angiotensin Type 1 Receptor Antibodies Together with De Novo Donor HLA Specific Antibodies on Graft Outcome in Heart Transplant Recipients

2013 ◽  
Vol 32 (4) ◽  
pp. S113 ◽  
Author(s):  
N.L. Reinsmoen ◽  
C.-H. Lai ◽  
J. Mirocha ◽  
K. Cao ◽  
G.D. Ong ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Negative Impact ◽  
Transplant Recipients ◽  
Specific Antibodies ◽  
Graft Outcome ◽  
Heart Transplant Recipients ◽  
Receptor Antibodies ◽  
Angiotensin Type

HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients

2020 ◽  
Vol 81 (7) ◽  
pp. 330-336
Author(s):  
Xiaohai Zhang ◽  
Evan Kransdorf ◽  
Ryan Levine ◽  
Jignesh K. Patel ◽  
Jon A. Kobashigawa
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Transplant Recipients ◽  
Specific Antibodies ◽  
Hla Dq ◽  
Heart Transplant Recipients ◽  
Donor Specific Antibodies

Single-centre first experience with everolimus and CSA for de novo heart transplant recipients

2005 ◽  
Vol 53 (S 3) ◽  
Author(s):  
H Lehmkuhl ◽  
M Dandel ◽  
C Knosalla ◽  
O Grauhan ◽  
M Jurmann ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Transplant Recipients ◽  
Single Centre ◽  
Heart Transplant Recipients

Cardiac Allograft Vasculopathy: Differences in De Novo and Maintenance Heart Transplant Recipients

2006 ◽  
Vol 82 (Supplement) ◽  
pp. S5-S12 ◽  
Author(s):  
Maria Frigerio ◽  
Andrea Garascia ◽  
Elena Roubina ◽  
Giada Distefano ◽  
Pedro Silva Orrego ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Transplant Recipients ◽  
Allograft Vasculopathy ◽  
Heart Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document